Protocol for casein kinase 1γ3 CSNK1G3 gene knockout and recombinant gene expression in cultured HeLa cells

Asako Goto1, Kentaro Hanada2

  • 1Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan; Department of Virology III, National Institute of Infectious Diseases, Musashimurayama City, Tokyo 208-0011, Japan.

STAR Protocols
|April 29, 2023
PubMed

Insights

This study details a protocol for gene knockout of CSNK1G3 and expression of CSNK1G1-3 in human cells using retroviral vectors. The methods cover genome editing, cDNA cloning, and expression verification for casein kinase 1γ research.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Casein kinase 1γ (CK1γ) is a subfamily within the larger casein kinase 1 family.
  • Understanding the function of CK1γ members requires robust genetic manipulation tools.

Purpose of the Study:

  • To establish a comprehensive protocol for gene knockout of CSNK1G3 in human cells.
  • To describe methods for cloning and expressing CSNK1G1-3 cDNAs using a retroviral vector system.

Main Methods:

  • Genome editing using sgRNA design, introduction into HeLa cells, and verification.
  • Cloning of human CSNK1G cDNAs.
  • Retroviral vector-mediated gene delivery into HeLa cells.
  • Expression verification via Western blot analysis.

Main Results:

  • Successful implementation of genome editing for CSNK1G3 knockout.
  • Efficient cloning and expression of CSNK1G1-3 cDNAs in human cells.
  • Demonstrated utility of the retroviral vector system for CK1γ subfamily studies.

Conclusions:

  • The presented protocol provides a reliable method for genetic manipulation of the CK1γ subfamily in human cells.
  • This toolkit facilitates further investigation into the biological roles of CSNK1G1, CSNK1G2, and CSNK1G3.
  • The study offers a foundation for future research on CK1γ in various cellular contexts.

Related Concept Videos